acalabrutinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

M.D. Anderson Cancer Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadgilbert's syndrome

I am/have/hadmeasurable disease

I am/have/hadlymphoma

I am/have/hadneutrophil count

I am/have/hadprothrombin

I am/have/hadplatelet count

I am/have/hadaptt

I am/have/hadpositron emission tomography

I am/have/hadct scan

I am/have/hadcervical cap

I am/have/hadantibody therapy

I am/have/hadhuman chorionic gonadotropin

I am/have/hadfollicular lymphoma

I am/have/hadblood transfusion

I am/have/hadstage iii grade 1 follicular lymphoma

I am/have/hadstage iv grade 2 follicular lymphoma

I am/have/hadabsolute neutrophil count

I am/have/hadstage iii grade 3 follicular lymphoma

I am/have/hadstage iv grade 3 follicular lymphoma

added new label for I am/have/had

more

I am looking for

I am looking foracalabrutinib

I am looking forrituximab

I am looking formonoclonal antibodies

I am looking forprothrombin

I am looking forgrowth factor

I am looking forlenalidomide

I am looking forhuman chorionic gonadotropin

I am looking formonoclonal protein

I am looking forbeta-human chorionic gonadotropin

I am looking fororal contraceptives

I am looking forbeta-hcg

I am looking forrevlimid

I am looking forbeta human chorionic gonadotropin

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Acalabrutinib Lenalidomide and Rituximab for the Treatment of CD20 Positive Stage III-IV Grade 1-3a Follicular Lymphoma

This phase II trial studies how well acalabrutinib, lenalidomide, and rituximab work in treating patients with CD20 positive stage III-IV, grade 1-3a follicular lymphoma. Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

positron emission tomography

antibody therapy

human chorionic gonadotropin

prothrombin

follicular lymphoma

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.